Fast, easy diagnostics for personalised phage therapybroad
Phagediag · Horizon Europe grant · 2023-02-01–2025-10-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2022-ACCELERATOR-01 · scheme HORIZON-EIC-ACC-BF · topic HORIZON-EIC-2022-ACCELERATOROPEN-01. CORDIS record →
Objective
Personalised phage therapy using magistral preparations of phages is among the most promising solutions to fight antimicrobial resistant infections, but this approach requires a rapid diagnostic that identifies the pathogen(s) involved in the infection and the phages active on them. Vésale Bioscience has developed the “Phagogram”, the first automated in-vitro diagnostic tool that enables a fast determination of bacteriophages suitable for treating a particular bacterial infection. It consists of a basic test kit (a disposable well plate with reagents), a high-performance luminometer and a dedicated software that proposes the best matching phage cocktail to treat the patient. Compared to the current diagnostic methodologies, which take up to 4-7 days, the Phagogram compares the activity of up to 96 phages on a bacterial culture within 2-3 hours, making phage susceptibility testing accessible for hospital microbiology labs and enabling personalized therapy on a routine basis.
Beneficiaries (1)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| Inteliphage | BE | coordinator | €1,800,000 | Yes |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.